Abstract
Epstein-Barr virus (EBV) infection has been causally associated with occurrence of many malignant neoplasms. EBV-encoded small RNAs (EBERs) have been detected from about 10% of gastric carcinoma tissue cells, suggesting that EBV infection is associated with the development of gastric carcinoma. The present study pooled the data from the papers concerning EBV-related gastric cancers and performed a meta-analysis of 22 research papers. Among these papers, a total of 5475 cases with gastric cancer were enrolled, of whom 411 cases were found EBV-positive, with the EBV-positive rate being 7.5%. Among the EBV-positive gastric cancer cases, the detection rate was 11.1% in males and 3.0% in females. Compared with EBV-negative gastric cancer, EBV-positive gastric cancer had less lymph node metastasis. Based on the histological typing, of the EBV-positive gastric cancers, the diffuse type was 8.1%, and intestinal type was 8.0%. The examined specimen types included stored paraffin blocks and fresh surgically removed specimens, their EBV positive rates were 7.9% and 6.5% respectively. In terms of geographical distribution, the detection rate of EBV-positive gastric cancer was 9.4% in America, 6.1% in Asia and 9.1% in Europe. Meta-analysis showed that EBV infection occurred only in gastric cancer tissue cells and was significantly associated with the patients’ gender, lymph node metastases, and the location where tumor tissue generated and geographical distribution (P<0.05), but was not significantly associated with the patients’ histological types of tumor and the types of specimens (P>0.05). These results suggested that EBV-positive gastric cancer has distinct clinicopathological features.
Similar content being viewed by others
References
Konturek P C, Konturek S J, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol, 2006, 57: 51–65
Thompson M P, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res, 2004, 10: 803–821 10.1158/1078-0432.CCR-0670-3, 1:CAS:528:DC%2BD2cXhtFCnsrY%3D, 14871955
Burke A P, Yen T S, Shekitka K M, et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol, 1990, 3: 377–380 1:STN:280:DyaK3czgtFOmug%3D%3D, 2163534
Shibata D, Weiss L M. Epstein-Barr virus-associated gastric Adenocarcinoma. Am J Pathol, 1992, 140: 769–774 1:STN:280:DyaK383it1SgtQ%3D%3D, 1314023
Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA, 1994, 91: 9131–9135 10.1073/pnas.91.19.9131, 1:CAS:528:DyaK2cXmtVajtLo%3D, 8090780
Gulley M L, Pulitzer D R, Eagan P A, et al. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 Expression and p53 accumulation. Hum Pathol, 1996, 27: 20–27 10.1016/S0046-8177(96)90133-1, 1:STN:280:DyaK287ksVOksQ%3D%3D, 8543306
Uozaki H, Fukayama M. Epstein-Barr virus and gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol, 2008, 1: 198–216 1:CAS:528:DC%2BD1cXpt1Gnu78%3D, 18784828
zur Hausen A, Brink A A, Craanen M E, et al. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res, 2000, 60: 2745–2748 10825150
Li S Y, Hou L T, Zhou T J. Study on the influence of EBV infection to bcl-2 expression in gastric carcinoma patients. Clin Focus, 2006, 21: 319–321
Li S Y, Zhu L H, Zhou T J. Study on EBV infection and expression of c-erbB-2 in gastric carcinoma patients. Chin J Zoonoses, 2006, 22: 606–608 1:CAS:528:DC%2BD2sXhtlWgtrrO
Li S Y, Zhang K, Zhou T J. Relativity between EBV infection and expression of cyclin D1 in gastric carcinoma patients. J Fourth Military Med Univ, 2006, 27: 1932–1933 1:CAS:528:DC%2BD1cXhtVektL4%3D
Li S Y, Hu J H, Zhou T J. Analyse the relativity of EBV infection with gastric carcinomas. Chin J Gerontol, 2007, 27: 2323–2325
Ryan J L, Morgan D R, Dominguez R L, et al. High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest, 2009, 89: 80–90 10.1038/labinvest.2008.103, 1:CAS:528:DC%2BD1MXhtVKntQ%3D%3D, 19002111
Vo Q N, Geradts J, Gulley M L, et al. Epstein-Barr virus in gastric adenocarcinoma: Associated with ethnicity and CDKN2A promoter methylation. J Clin Pathol, 2002, 55: 669–675 10.1136/jcp.55.9.669, 1:STN:280:DC%2BD38vmtlSntg%3D%3D, 12194996
Truong C D, Feng W, Li W, et al. Characteristics of Epstein-Barr virus-associated gastric cancer: A study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res, 2009, 28: 1–9 10.1186/1756-9966-28-14
Alipov G, Nakayama T, Nakashima M, et al. Epstein-Barr virus associated gastric carcinoma in Kazakhstan. World J Gastroenterol, 2005, 11: 27–30 15609391
Lee H S, Chang M S, Yang H K, et al. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res, 2004, 10: 1698–1705 10.1158/1078-0432.CCR-1122-3, 1:CAS:528:DC%2BD2cXhvFCltro%3D, 15014022
Herrera-Goepfert R, Akiba S, Koriyama C, et al. Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population. World J Gastroenterol, 2005, 11: 6096–6103 16273633
van Beek J, zur Hausen A, Klein Kranenbarg E, et al. EBV-positive gastric adenocarcinomas: A distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol, 2004, 22: 664–670 10.1200/JCO.2004.08.061, 14966089
Wang K J, Wang R T. Meta-analysis on the epidemiology of helicobacter pylori infection in China. Chin J Epidemiol, 2003, 24: 443–446
Lee J H, Kim S H, Han S H, et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: A meta-analysis. J Gastroenterol Hepatol, 2009, 24: 354–365 10.1111/j.1440-1746.2009.05775.x, 19335785
Lima V P, de Lima M A, André A R, et al. H pylori (Cag A) and Epstein-Barr virus infection in gastric carcinomas: Correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol, 2008, 14: 884–891 10.3748/wjg.14.884, 1:CAS:528:DC%2BD1cXjsFyksrc%3D, 18240345
Lopes L F, Bacchi M M, Elgui-de-Oliveira D, et al. Epstein-Barr virus infection and gastric carcinoma in Sao Paulo State, Brazil. Braz J Med Biol Res, 2004, 37: 1707–1712 1:STN:280:DC%2BD2crksVyhtQ%3D%3D, 15517087
Begnami M D, Montagnini A L, Vettore A L, et al. Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas. World J Gastroenterol, 2006, 12: 4959–4965 1:CAS:528:DC%2BD28XhtVehtrfM, 16937490
Luo B, Wang Y, Wang X F, et al. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori end expression of c-met and c-myc in gastric carcinomas. World J Gastroenterol, 2006, 12: 1842–1848 1:CAS:528:DC%2BD28Xksl2ntLk%3D, 16609989
Abdirad A, Ghaderi-Sohi S, Shuyama K, et al. Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades. Diagn Pathol, 2007, 2: 1–9 10.1186/1746-1596-2-25
Shibata D, Hawes D, Stemmermann G N, et al. Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev, 1993, 2: 213–217 1:STN:280:DyaK3szgs1Wktw%3D%3D, 8391356
Karim N, Pallesen G. Epstein-Barr virus(EBV) and gastric carcinoma in Malaysian patients. Malaysian J Pathol, 2003, 25: 45–47
Oda K, Koda K, Takiguchi N, et al. Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer, 2003, 6: 173–178 10.1007/s10120-003-0247-2, 14520531
Jung I M, Chung J K, Kim Y A, et al. Epstein-Barr virus, Beta catenin, and E-cadherin in gastric carcinomas. J Korean Med Sci, 2007, 22: 855–861 10.3346/jkms.2007.22.5.855, 1:CAS:528:DC%2BD2sXhsVWrtb7O, 17982235
Chang M S, Lee H S, Jung E J, et al. Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas. Anticancer Res, 2007, 27: 785–792 1:CAS:528:DC%2BD2sXltVKmtr0%3D, 17465203
Kang G H, Lee S, Kim W H, et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol, 2002, 160: 787–794 1:CAS:528:DC%2BD38XisVemsbg%3D, 11891177
van Rees B P, Caspers E, zur Hausen A, et al. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am J Pathol, 2002, 161: 1207–1213 12368194
van Beek J, zur Hausen A, Kranenbarg E K, et al. A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas. Mod Pathol, 2002, 15: 870–877 10.1097/01.MP.0000024147.43288.B1, 12181273
Nicholls J M, Agathanggelou A, Fung K, et al. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt’s lymphoma. J Pathol, 1997, 183: 164–168 10.1002/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J, 1:STN:280:DyaK1c%2FltFCltQ%3D%3D, 9390028
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, S., Du, H., Wang, Z. et al. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci. China Life Sci. 53, 524–530 (2010). https://doi.org/10.1007/s11427-010-0082-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-010-0082-8